NCT02921893View on ClinicalTrials.gov

Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

April 21, 2022

Study Completion Date

May 13, 2024

Conditions

PlasmacytomaPOEMS Syndrome

Interventions

DRUG

Dexamethasone

Given PO

DRUG

Ixazomib Citrate

Given PO

DRUG

Lenalidomide

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER